Nakamura, Yuto

Dr. Yuto Nakamura worked at Tokyo New Drug Research Laboratories, Kowa Company, Ltd. since he graduated from the University of Toyama, Japan in 2015. At University of Toyama, he studied metabolic diseases, especially non-alcoholic steatohepatitis (NASH), and he completed his Master’s course in Pharmaceutical Science under the guidance of Dr. Toshiyasu Sasaoka. Since joining Kowa, he has been engaged in drug development research regarding ophthalmology. Then, he moved on to the laboratory of the graduate school of medicine, department of metabolic medicine at Osaka University, Japan as a Kowa researcher. He obtained his doctorate in 2021 under the supervision of Dr. Iichiro Shimomura and Dr. Shunbun Kita. He investigated the relationship between adiponectin and therapeutic efficacy of Mesenchymal stem cells (MSCs), and uncovered that the circulating adiponectin concentration is closely related to the effect of MSCs for heart failure in mice.

He is engaged in research in the field of metabolic disease at CICS since Dec 2021 as a research fellow in Dr. Yusuke Sasaki’s group. He will be focusing on searching for new druggable targets in metabolic disease.